Symposium on Modern Trends in Radiopharmaceutical SciencesInstitute of Neurosciences and Medicine, INM-5: Nuclear ChemistryForschungszentrum Jülich (FZJ), Germany, 05 May 2009 Hörsaal, Gebäude 05.3 Programme |
08:45 Uhr |
Welcome and opening Prof. Dr. S. Schmidt, Board of Directors, FZJ, Jülich H.H. Coenen, President SRS, FZJ, Jülich |
09:00 Uhr |
Can photons meet the challenge of producing Mo-99? T. Ruth, TRIUMF, Vancouver |
09:30 Uhr |
Nuclear data for the production of non-standard PET-radionuclides. S.M. Qaim, FZJ, Jülich |
10:00 Uhr |
Preparation and use of high specific activity radiometals. C. Cutler, University of Missouri, Columbia, MO |
10:30 Uhr |
Coffee break |
11:00 Uhr |
Recent attempts for the application of Re-188 in cancer radiotherapy. U. Mazzi, University of Padua, Padua |
11:30 Uhr |
New studies with radiolabled bombesin derivatives for imaging and therapy. W. Volkert, University of Missouri, Columbia, MO |
12:00 Uhr |
Hypoxic tumour stem cell as a target for PET imaging/radiotherapy. Y. Fujibayashi, University of Fukui, Fukui |
12:30 Uhr |
Lunch break |
14:00 Uhr |
B12-derivates – A promising tumour biomarker. P. A. Schubiger, ETH/PSI, Zürich |
14:30 Uhr |
Multimeric receptor binding and the role of ligand rigidity. M. Eisenhut, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg |
15:00 Uhr |
Radiopharmaceuticals for imaging PgP function with PET; [11C]Verapamil, its radiometabolite [11C]D617 and the new radiopharmaceutical [11C]Laniquidar. A.D. Windhorst, Free University of Amsterdam, Amsterdam |
15:30 Uhr |
Coffee break |
16:00 Uhr |
Changes in latitudes, changes in attitudes. W.C. Eckelman, Molecular Tracer LLC, Bethesda, MD |
16:30 Uhr |
EU and US regulatory considerations for PET radiopharmaceuticals. S. Schwarz, Washington University, St. Louis, MO |
17:00 Uhr |
Training program for PET radiopharmaceutical sciences: Addressing a global shortage. S. Mcquarrie, University of Alberta, Edmonton |
17:30 Uhr |
Round table discussion |
18:00 Uhr |
Closing, farewell |